Meilei Harima

2.6k total citations
60 papers, 2.2k citations indexed

About

Meilei Harima is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Meilei Harima has authored 60 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 13 papers in Cell Biology. Recurrent topics in Meilei Harima's work include Endoplasmic Reticulum Stress and Disease (12 papers), Curcumin's Biomedical Applications (10 papers) and Advanced Glycation End Products research (10 papers). Meilei Harima is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (12 papers), Curcumin's Biomedical Applications (10 papers) and Advanced Glycation End Products research (10 papers). Meilei Harima collaborates with scholars based in Japan, United States and Indonesia. Meilei Harima's co-authors include Kenichi Watanabe, Kenji Suzuki, Rajarajan A. Thandavarayan, Vivian Soetikno, Flori R. Sari, Somasundaram Arumugam, Arun Prasath Lakshmanan, Vijayakumar Sukumaran, Makoto Kodama and Hiroshi Kawachi and has published in prestigious journals such as Biochemical Pharmacology, Life Sciences and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Meilei Harima

59 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meilei Harima Japan 28 803 427 356 347 302 60 2.2k
Arun Prasath Lakshmanan Japan 27 798 1.0× 342 0.8× 355 1.0× 381 1.1× 233 0.8× 49 2.0k
Somasundaram Arumugam Japan 32 1.0k 1.2× 337 0.8× 365 1.0× 325 0.9× 459 1.5× 86 2.8k
Vivian Soetikno Indonesia 23 616 0.8× 368 0.9× 361 1.0× 318 0.9× 220 0.7× 67 1.8k
Vijayakumar Sukumaran Japan 26 736 0.9× 227 0.5× 372 1.0× 468 1.3× 221 0.7× 43 2.0k
Flori R. Sari Japan 19 569 0.7× 300 0.7× 281 0.8× 291 0.8× 139 0.5× 32 1.4k
Yong Pan China 20 920 1.1× 265 0.6× 221 0.6× 314 0.9× 451 1.5× 40 2.1k
Nehal M. Elsherbiny Egypt 36 1.2k 1.4× 78 0.2× 204 0.6× 142 0.4× 304 1.0× 114 3.2k
Veera Ganesh Yerra India 22 839 1.0× 69 0.2× 272 0.8× 125 0.4× 203 0.7× 38 2.1k
Yoichi Sunagawa Japan 21 911 1.1× 778 1.8× 127 0.4× 272 0.8× 128 0.4× 94 1.9k

Countries citing papers authored by Meilei Harima

Since Specialization
Citations

This map shows the geographic impact of Meilei Harima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilei Harima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilei Harima more than expected).

Fields of papers citing papers by Meilei Harima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meilei Harima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilei Harima. The network helps show where Meilei Harima may publish in the future.

Co-authorship network of co-authors of Meilei Harima

This figure shows the co-authorship network connecting the top 25 collaborators of Meilei Harima. A scholar is included among the top collaborators of Meilei Harima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meilei Harima. Meilei Harima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Kenichi, Rejina Afrin, Remya Sreedhar, et al.. (2020). Pharmacological Investigation of Ceraceomyces tessulatus (Agaricomycetes) in Mice with Nonalcoholic Steatohepatitis. International journal of medicinal mushrooms. 22(7). 683–692. 4 indexed citations
2.
Kobayashi, Mariko, Hiroki Katagiri, Hitoshi Yamada, et al.. (2017). <b>Evaluation of Drug Release from a Bisoprolol Patch Preparation and its Pharmacokinetics after Eight-hour Application </b>. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 48(2). 27–30.
3.
Arumugam, Somasundaram, Remya Sreedhar, Vengadeshprabhu Karuppagounder, et al.. (2017). Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy. Cardiovascular Therapeutics. 35(5). 3 indexed citations
4.
Afrin, Rejina, Somasundaram Arumugam, Mir Imam Ibne Wahed, et al.. (2017). Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation. International Immunopharmacology. 44. 174–182. 96 indexed citations
5.
Karuppagounder, Vengadeshprabhu, Somasundaram Arumugam, Rajarajan A. Thandavarayan, et al.. (2016). Curcumin alleviates renal dysfunction and suppresses inflammation by shifting from M1 to M2 macrophage polarization in daunorubicin induced nephrotoxicity in rats. Cytokine. 84. 1–9. 47 indexed citations
6.
Pitchaimani, Vigneshwaran, Somasundaram Arumugam, Rajarajan A. Thandavarayan, et al.. (2016). Hypothalamic glucagon signaling in fasting hypoglycemia. Life Sciences. 153. 118–123. 3 indexed citations
7.
Sreedhar, Remya, Somasundaram Arumugam, Vengadeshprabhu Karuppagounder, et al.. (2015). Jumihaidokuto effectively inhibits colon inflammation and apoptosis in mice with acute colitis. International Immunopharmacology. 29(2). 957–963. 10 indexed citations
8.
Arumugam, Somasundaram, Remya Sreedhar, Rajarajan A. Thandavarayan, et al.. (2015). Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium. Cytokine. 74(2). 305–312. 22 indexed citations
9.
Afrin, Rejina, Somasundaram Arumugam, Vivian Soetikno, et al.. (2014). Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats. Free Radical Research. 49(3). 279–289. 57 indexed citations
10.
Pitchaimani, Vigneshwaran, Somasundaram Arumugam, Rajarajan A. Thandavarayan, et al.. (2014). Fasting mediated increase in p-BADser155 and p-AKTser473 in the prefrontal cortex of mice. Neuroscience Letters. 579. 134–139. 3 indexed citations
11.
Arumugam, Somasundaram, Remya Sreedhar, Shizuka Miyashita, et al.. (2014). Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. Experimental and Molecular Pathology. 97(1). 137–143. 14 indexed citations
12.
Arumugam, Somasundaram, Wawaimuli Arozal, Rajarajan A. Thandavarayan, et al.. (2013). Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats. International Immunopharmacology. 18(2). 282–289. 32 indexed citations
13.
Arumugam, Somasundaram, Rajarajan A. Thandavarayan, Punniyakoti T. Veeraveedu, et al.. (2012). Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy. Journal of Cellular and Molecular Medicine. 16(9). 2176–2185. 31 indexed citations
14.
Lakshmanan, Arun Prasath, Meilei Harima, Kenji Suzuki, et al.. (2012). The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: A differential role of unfolded protein response (UPR) signaling proteins. The International Journal of Biochemistry & Cell Biology. 45(2). 438–447. 86 indexed citations
15.
Lakshmanan, Arun Prasath, Meilei Harima, Vijayakumar Sukumaran, et al.. (2011). Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats. Biochemical Pharmacology. 83(5). 653–660. 37 indexed citations
16.
Lakshmanan, Arun Prasath, Rajarajan A. Thandavarayan, Kenichi Watanabe, et al.. (2011). Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice. Molecular and Cellular Endocrinology. 348(1). 104–111. 51 indexed citations
17.
Lakshmanan, Arun Prasath, Kenichi Watanabe, Rajarajan A. Thandavarayan, et al.. (2011). Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1–7)masreceptor expression associated with its PPAR-γ agonist action. Free Radical Research. 45(5). 575–584. 77 indexed citations
18.
Sari, Flori R., Bambang Widyantoro, Rajarajan A. Thandavarayan, et al.. (2011). Attenuation of CHOP-mediated Myocardial Apoptosis in Pressure-overloaded Dominant Negative p38α Mitogen-activated Protein Kinase Mice. Cellular Physiology and Biochemistry. 27(5). 487–496. 39 indexed citations
19.
Lakshmanan, Arun Prasath, Rajarajan A. Thandavarayan, Suresh S. Palaniyandi, et al.. (2011). Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice. European Journal of Pharmaceutical Sciences. 44(5). 627–634. 64 indexed citations
20.
Arozal, Wawaimuli, Kenichi Watanabe, Punniyakoti T. Veeraveedu, et al.. (2010). Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. Free Radical Research. 44(11). 1369–1377. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026